MitoAction meeting discussing multiple specialists.
Learn about the new draft CDC Opioid Guideline, how it impacts the mito community and how you can raise your voice to address important...
Join us for an informative webinar exploring KYGEVVI™ (doxecitine and doxribtimine), the first FDA-approved treatment for thymidine kinase 2 deficiency (TK2d) in adults and...
Summertime is a time of changed routines for many Mito families. Camp programs, such as those supported by the Matthew Harty Camper Fund, provide...